Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP867431.RAYnU4isRd40z3IjIuL9UxRkNQoYj_B3Q9dl8EaJNSklk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP867431.RAYnU4isRd40z3IjIuL9UxRkNQoYj_B3Q9dl8EaJNSklk130_assertion type Assertion NP867431.RAYnU4isRd40z3IjIuL9UxRkNQoYj_B3Q9dl8EaJNSklk130_head.
- NP867431.RAYnU4isRd40z3IjIuL9UxRkNQoYj_B3Q9dl8EaJNSklk130_assertion description "[In addition, we found that p16 (INK4a) is also downregulated in immortal cells and that coexpression of CREG1 and p16 (INK4a) , an inhibitor of CDK4/6 and Rb phosphorylation, has a greater effect than either CREG1 and p16 (INK4a) alone to reduce cell growth, induce cell cycle arrest and cellular senescence in immortal LFS fibroblasts, osteosarcoma and fibrosarcoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867431.RAYnU4isRd40z3IjIuL9UxRkNQoYj_B3Q9dl8EaJNSklk130_provenance.
- NP867431.RAYnU4isRd40z3IjIuL9UxRkNQoYj_B3Q9dl8EaJNSklk130_assertion evidence source_evidence_literature NP867431.RAYnU4isRd40z3IjIuL9UxRkNQoYj_B3Q9dl8EaJNSklk130_provenance.
- NP867431.RAYnU4isRd40z3IjIuL9UxRkNQoYj_B3Q9dl8EaJNSklk130_assertion SIO_000772 21263217 NP867431.RAYnU4isRd40z3IjIuL9UxRkNQoYj_B3Q9dl8EaJNSklk130_provenance.
- NP867431.RAYnU4isRd40z3IjIuL9UxRkNQoYj_B3Q9dl8EaJNSklk130_assertion wasDerivedFrom befree-2016 NP867431.RAYnU4isRd40z3IjIuL9UxRkNQoYj_B3Q9dl8EaJNSklk130_provenance.
- NP867431.RAYnU4isRd40z3IjIuL9UxRkNQoYj_B3Q9dl8EaJNSklk130_assertion wasGeneratedBy ECO_0000203 NP867431.RAYnU4isRd40z3IjIuL9UxRkNQoYj_B3Q9dl8EaJNSklk130_provenance.